To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt. It is the parental prodrug of trovafloxacin (Trovan) meant for intravenous administration. Trovafloxacin is a broad-spectrum antibiotic introduced in 1998 which encountered criticism for its Nigerian trials and adverse clinical reactions.
Additional recommended knowledge
Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in 2001.
Categories: Fluoroquinolone antibiotics | Prodrugs | Withdrawn drugs
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alatrofloxacin". A list of authors is available in Wikipedia.|